Drug Resistance Updates
SCIE国际简称：DRUG RESIST UPDATE 参考译名：耐药性更新
主要研究方向：医学-药学 非预警期刊 审稿周期： 约稿?周期不定
《耐药性更新》(Drug Resistance Updates)是一本由Churchill Livingstone出版的以医学-药学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。
Drug Resistance Updates is a bimonthly publication that contains thought-provoking reviews on important developments in drug resistance in infectious disease and cancer as well as novel drugs and strategies to overcome drug resistance.
It covers both basic research and clinical aspects of drug resistance, and involves disciplines as diverse as molecular biology, biochemistry, cell biology, pharmacology, microbiology, preclinical therapeutics, oncology and clinical medicine.
Articles are written by leaders in the field, in response to an invitation from the Editors, and are peer-reviewed prior to publication. Articles are clear, readable, and up-to-date, suitable for a multidisciplinary readership and include schematic diagrams and other illustrations conveying the major points of the article. The goal is to highlight recent areas of growth and put them in perspective.
*Expert reviews in clinical and basic drug resistance research in oncology and infectious disease
*Describes emerging technologies and therapies, particularly those that overcome drug resistance
*Emphasises common themes in microbial and cancer research
Drug Resistance Updates期刊信息
- ISSN：1368-7646
- 出版语言：English
- 是否OA：未开放
- E-ISSN：1532-2084
- 出版地区：ENGLAND
- 是否预警：否
- 出版商：Churchill Livingstone
- 出版周期：Bimonthly
- 创刊时间：1998
- 开源占比：0.3125
- Gold OA文章占比：40.00%
- OA被引用占比：0.0794...
- 出版国人文章占比：0.05
- 出版撤稿占比：0
- 研究类文章占比：54.17%
Drug Resistance Updates CiteScore评价数据（2024年最新版）
| CiteScore | SJR | SNIP | CiteScore 指数 | ||||||||||||||||||||||||
| 26.2 | 4.665 | 2.998 |
|
名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量 注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。
Drug Resistance Updates中科院评价数据
中科院 2023年12月升级版
| Top期刊 | 综述期刊 | 大类学科 | 小类学科 | ||
| 否 | 是 | 医学 | 1区 | PHARMACOLOGY & PHARMACY 药学 | 1区 |
中科院 2022年12月升级版
| Top期刊 | 综述期刊 | 大类学科 | 小类学科 | ||
| 是 | 是 | 医学 | 1区 | PHARMACOLOGY & PHARMACY 药学 | 1区 |
中科院 2021年12月旧的升级版
| Top期刊 | 综述期刊 | 大类学科 | 小类学科 | ||
| 是 | 是 | 医学 | 1区 | PHARMACOLOGY & PHARMACY 药学 | 1区 |
中科院 2021年12月基础版
| Top期刊 | 综述期刊 | 大类学科 | 小类学科 | ||
| 是 | 是 | 医学 | 1区 | PHARMACOLOGY & PHARMACY 药学 | 1区 |
中科院 2021年12月升级版
| Top期刊 | 综述期刊 | 大类学科 | 小类学科 | ||
| 是 | 是 | 医学 | 1区 | PHARMACOLOGY & PHARMACY 药学 | 1区 |
中科院 2020年12月旧的升级版
| Top期刊 | 综述期刊 | 大类学科 | 小类学科 | ||
| 是 | 是 | 医学 | 1区 | PHARMACOLOGY & PHARMACY 药学 | 1区 |
Drug Resistance Updates JCR评价数据（2023-2024年最新版）
| 按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
| 学科：PHARMACOLOGY & PHARMACY | SCIE | Q1 | 3 / 354 |
99.3% |
| 按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
| 学科：PHARMACOLOGY & PHARMACY | SCIE | Q1 | 5 / 354 |
98.73% |
Drug Resistance Updates历年数据统计
影响因子
中科院分区
Drug Resistance Updates中国学者发文选摘
-
1、CHD4 promotes acquired chemoresistance and tumor progression by activating the MEK/ERK axis
Author: Wu, Jing; Zhou, Zhijun; Li, Jin; Liu, Huifang; Zhang, Huaqi; Zhang, Junchang; Huang, Weibin; He, Yulong; Zhu, Shiyu; Huo, Mingyu; Liu, Mingyang; Zhang, Changhua
Journal: DRUG RESISTANCE UPDATES. 2023; Vol. 66, Issue , pp. -. DOI: 10.1016/j.drup.2022.100913
-
2、Overcoming cancer chemotherapy resistance by the induction of ferroptosis
Author: Wang, Yumin; Wu, Xiaorui; Ren, Zhao; Li, Yulin; Zou, Wailong; Chen, Jichao; Wang, Hongquan
Journal: DRUG RESISTANCE UPDATES. 2023; Vol. 66, Issue , pp. -. DOI: 10.1016/j.drup.2022.100916
-
3、Single-cell transcriptional profiling uncovers the association between EOMES+CD8+T cells and acquired EGFR-TKI resistance
Author: Wang, Guosheng; Sun, Jiaxing; Zhang, Jing; Zhu, Qiping; Lu, Jingjing; Gao, Shaoyong; Wang, Feilong; Yin, Qi; Wan, Yuan; Li, Qiang
Journal: DRUG RESISTANCE UPDATES. 2023; Vol. 66, Issue , pp. -. DOI: 10.1016/j.drup.2022.100910
-
4、Resistance-proof antimicrobial drug discovery to combat global antimicrobial resistance threat
Author: Upadhayay, Aditya; Ling, Jingjing; Pal, Dharm; Xie, Yuhao; Ping, Feng-Feng; Kumar, Awanish
Journal: DRUG RESISTANCE UPDATES. 2023; Vol. 66, Issue , pp. -. DOI: 10.1016/j.drup.2022.100890
-
5、CCT251545 enhances drug delivery and potentiates chemotherapy in multidrug-resistant cancers by Rac1-mediated macropinocytosis
Author: Qin, Siyuan; Zhang, Zhe; Huang, Zhao; Luo, Yinheng; Weng, Ningna; Li, Bowen; Tang, Yongquan; Zhou, Li; Jiang, Jingwen; Lu, Yi; Shao, Jichun; Xie, Na; Nice, Edouard C.; Chen, Zhe-Sheng; Zhang, Jian; Huang, Canhua
Journal: DRUG RESISTANCE UPDATES. 2023; Vol. 66, Issue , pp. -. DOI: 10.1016/j.drup.2022.100906
-
6、Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade
Author: Pang, Kun; Shi, Zhen-Duo; Wei, Liu-Ya; Dong, Yang; Ma, Yu-Yang; Wang, Wei; Wang, Guang-Yue; Cao, Ming-Yang; Dong, Jia-Jun; Chen, Yu-Ang; Zhang, Peng; Hao, Lin; Xu, Hao; Pan, Deng; Chen, Zhe-Sheng; Han, Cong-Hui
Journal: DRUG RESISTANCE UPDATES. 2023; Vol. 66, Issue , pp. -. DOI: 10.1016/j.drup.2022.100907
-
7、A highly potent small-molecule antagonist of exportin-1 selectively eliminates CD44(+)CD24(-) enriched breast cancer stem-like cells
Author: Liu, Caigang; Zhang, Yixiao; Gao, Jiujiao; Zhang, Qi; Sun, Lisha; Ma, Qingtian; Qiao, Xinbo; Li, Xinnan; Liu, Jinchi; Bu, Jiawen; Zhang, Zhan; Han, Ling; Zhao, Dongyu; Yang, Yongliang
Journal: DRUG RESISTANCE UPDATES. 2023; Vol. 66, Issue , pp. -. DOI: 10.1016/j.drup.2022.100903
-
8、KIAA1429 promotes tumorigenesis and gefitinib resistance in lung adenocarcinoma by activating the JNK/ MAPK pathway in an m(6)A-dependent manner
Author: Lin, Xi; Ye, Rongyi; Li, Zhiming; Zhang, Bingli; Huang, Yuji; Du, Jiaxin; Wang, Bo; Meng, Hao; Xian, Hongyi; Yang, Xingfen; Zhang, Xin; Zhong, Yizhou; Huang, Zhenlie
Journal: DRUG RESISTANCE UPDATES. 2023; Vol. 66, Issue , pp. -. DOI: 10.1016/j.drup.2022.100908
Drug Resistance Updates同类期刊
-
公共卫生前沿
Frontiers In Public Health
中科院 3区 JCR Q2
-
药理学前沿
Frontiers In Pharmacology
中科院 2区 JCR Q1
-
生物医学与药物治疗
Biomedicine & Pharmacotherapy
中科院 2区 JCR Q1
-
探索肿瘤学
Discover Oncology
中科院 4区 JCR Q2
-
Bmc精神病学
Bmc Psychiatry
中科院 2区 JCR Q2
-
材料化学杂志 B
Journal Of Materials Chemistry B
中科院 3区 JCR Q1
-
Bmc神经病学
Bmc Neurology
中科院 3区 JCR Q3
-
美康
Medcomm
中科院 3区 JCR Q1
免责声明
若用户需要出版服务，请联系出版商：CHURCHILL LIVINGSTONE, JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH, SCOTLAND, MIDLOTHIAN, EH1 3AF。